DFine’s STAR Spinal Tumor Ablation System To Hit U.S. Market In Q4

Josh SandbergJanuary 23, 2012

580 Less than a minute

DFine plans to begin a gradual commercial launch late this year of its STAR system, designed to help cancer patients suffering from painful metastases in the spine.

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

DFine’s STAR Spinal Tumor Ablation System To Hit U.S. Market In Q4

Josh Sandberg

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Geisinger, Medacta announce first shoulder replacement with lifetime guarantee

The commercialization of Bioretec’s RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement

Josh Sandberg

Related Articles

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

DISC Surgery Center Adds Renowned Doctors to Medical Team

Spineart Celebrates 100,000 Ti-Life Technology Cages Sold Worldwide

Spineway: a week dedicated to medical excellence with more than 20 surgeons trained

Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash

Geisinger, Medacta announce first shoulder replacement with lifetime guarantee

The commercialization of Bioretec’s RemeOs™ Trauma Screw in the U.S. proceeds with the signing of new logistics agreement